Sulfacetamide sodium ophthalmic Pregnancy and Breastfeeding Warnings
Sulfacetamide sodium ophthalmic Pregnancy Warnings
Sodium sulfacetamide ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Sulfonamides have been reported to cross the placenta to the fetus during all stages of gestation. However, even when taken orally, sulfonamides have not been reported to pose a significant teratogenic risk; although there is a risk of kernicterus in the newborn. With the maternal blood levels expected when the drug is administered by the ophthalmic route, risk to the fetus would be expected to be minimal. Sodium sulfacetamide is only recommended for use during pregnancy when benefit outweighs risk.
Sulfacetamide sodium ophthalmic Breastfeeding Warnings
There are no data on the excretion of sodium sulfacetamide ophthalmic into human milk. Systemic sulfonamides are excreted into breast milk. The manufacturer recommends that due to the potential for the development of kernicterus in neonates, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Some systemic sulfonamides are considered compatible with breast-feeding of healthy full-term infants by the American Academy of Pediatrics.
- sulfacetamide drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.